CORCEPT THERAPEUTICS INC (CORT)
Pharmaceutical Preparations · Healthcare · $8.5B
Intrinsic Value (Consensus)
$12.98
Current Price
$79.93
Margin of Safety
-83.8%
83.8% Above Intrinsic Value
Value: $13
Price: $80
Valuation Model Estimates
Current Price: $79.93
DCF (Discounted Cash Flow)
$16.96
Graham Number
$10.62
Earnings Power Value
$7.96
Relative Value (P/E)
$16.40
Dividend Discount Model
Not applicable
—
Consensus Value
$12.98
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
66
Profitability
22/25
Strength
24/25
Valuation
7/25
Growth
13/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $0.82
- EPS (Forward)
- $0.84
- Book Value
- $6.11
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 15.4%
- Debt/Equity
- 7%
- Revenue Growth
- 12.8%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance